The Cell Therapy Catapult, focused on developing the UK cell industry, has teamed up with the UK Regenerative Medicine Platform, the Knowledge Transfer Network and the Association of Medical Research Charities in order to develop a database of funding for cell therapy research in the UK.
The database launches today and has identified more than 100 sources of funding from 34 organizations totalling over £3 billion ($4.7 billion) where cell therapies are believed to be eligible, with around £100 million earmarked specifically for the sector.
It is fully searchable and designed to help researchers identify appropriate sources of funding for their work, as well as giving an up-to-date picture of the UK environment, and is categorized by research stage, eligibility criteria, therapeutic area and closing data.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze